February 2008
Volume 18, Issue 2

Meeting on Key Issues in TB Drug Development
May 5 - 6, 2008, New Delhi, India

Open Forum 3 is the third in a series of two-day Open Forum meetings aiming to discuss key issues in tuberculosis (TB) drug development, with a special focus on regulatory affairs. The Forum will include sessions on the current global TB drug development portfolio, key issues in the critical path to TB drug registration, designing pivotal trials, conducting registration trials in high burden countries, challenges in TB drug development for resistant disease, and developing regimens containing multiple novel agents. These meetings are designed to bring together regulators, TB drug developers and other interested stakeholders such as TB care providers, public health policy-makers, and community advocates from both major industrialized and high burden countries.

The meeting is being organized and sponsored by Global Alliance for TB Drug Development (TB Alliance), the Bill & Melinda Gates Foundation, The Stop TB Partnership Working Group on New Drugs, and Treatment Action Group.

The meeting is supported in part by unrestricted educational grants from AstraZeneca, Bayer, GlaxoSmithKline and Johnson & Johnson/Tibotec.

Pre-registration is required and registration is free. For more information about this event and to register, please go to: http://www.tballiance.org/events/openforum3.php.

For inquiries, please contact the Conference Secretariat at rsvp@tballiance.org.

< Previous Article | Next Article >

In the IDSA Journals
Europe Reports High Percentage of Oseltamivir-resistant Influenza Virus
EIN: Decolonize MRSA Patients or Not?
Multidrug-resistant Staph Reported among MSM
Health Alerts, Drug Approvals, Recalls, Adverse Events
IDSA Policy & Advocacy Update: IDSA Opposes Anti-Thimerosal Legislation
CDC Survey Shows Less Effective Flu Medications Still Used
Third Seasonal and Pandemic Influenza Meeting: May 18-20
Meeting on Key Issues in TB Drug Development
Welcome, New IDSA Members!
Calendar of Future Meetings and Events
CMS Requires NPI on Claims Starting March 1

Dates to Remember

Oct. 25-29, 2008
IDSA/ICAAC Joint Meeting
Washington, DC
Abstract submission deadline: May 19, 2008

June 3-4, 2008
Fellows' In-Training Exam

Oct. 29-Nov. 1, 2009
47th Annual Meeting of IDSA
Philadelphia, PA


Search Back Issues
Forward this Issue
Print-Friendly Version

Copyright IDSA 2008 Infectious Diseases Society of America 1300 Wilson Boulevard, Suite 300 Arlington, VA 22209 info@idsociety.org

Home Page Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA